A Trail of Sperstent® Used for Residual Lesions of Femoropopliteal Arteries
A Trail of Sperstent® Used for Residual Lesions of Femoropopliteal Arteries
Recruiting · NCT06539689 · Registry updated 2024-08-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Trail of Sperstent® Used for Residual Lesions of Femoropopliteal Arteries | Arterial Occlusive Diseases, Constriction, Pathologic, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, peripheral arterial disease, peripheral vascular disease, vascular disorder | Recruiting | Not applicable | 2024-08-06 | NCT06539689 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| FrontAce Scientific Co., Ltd | 1 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Affiliated Hospital of Nantong University | Nantong | China | 14 |
| Beijing Friendship Hospital, Capital Medical University | Beijing | China | 21 |
| First Affiliated Hospital of Zhengzhou University | Zhengzhou | China | 8 |
| Hospital of Chengdu University of TCM | Chengdu | China | 1 |
| Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology | Wuhan | China | 1 |
| Nanjing Drum Tower Hospital | Nanjing | China | 33 |
| Renji Hospital, Shanghai Jiao Tong University School of Medicine | Shanghai | China | 11 |
| Shanghai East Hospital | Shanghai | China | 33 |
| The Affiliated Hospital of Southwest Medical University | Luzhou | China | 11 |
| The First Affiliated Hospital of Chongqing Medical University | Chongqing | China | 38 |
| The First Affiliated Hospital, Zhejiang University School of Medicine | Hangzhou | China | 29 |
| The Second Hospital of Hebei Medical University | Shijiazhuang | China | 20 |